Susana Arrigain
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 31 | 2023 | 653 | 2.360 |
Why?
| | Tissue Donors | 9 | 2025 | 424 | 1.320 |
Why?
| | Kidney Transplantation | 12 | 2025 | 704 | 1.280 |
Why?
| | Lung Transplantation | 10 | 2025 | 338 | 1.070 |
Why?
| | Tissue and Organ Procurement | 8 | 2025 | 346 | 0.920 |
Why?
| | Glomerular Filtration Rate | 22 | 2023 | 760 | 0.830 |
Why?
| | Kidney Failure, Chronic | 12 | 2025 | 598 | 0.810 |
Why?
| | Registries | 30 | 2025 | 2385 | 0.800 |
Why?
| | Liver Transplantation | 6 | 2026 | 823 | 0.800 |
Why?
| | Transplant Recipients | 6 | 2025 | 180 | 0.640 |
Why?
| | End Stage Liver Disease | 3 | 2025 | 94 | 0.590 |
Why?
| | Waiting Lists | 6 | 2025 | 263 | 0.560 |
Why?
| | Organ Transplantation | 3 | 2025 | 248 | 0.520 |
Why?
| | Graft Survival | 7 | 2025 | 526 | 0.520 |
Why?
| | Social Determinants of Health | 3 | 2025 | 301 | 0.490 |
Why?
| | Proportional Hazards Models | 19 | 2025 | 1325 | 0.460 |
Why?
| | Middle Aged | 65 | 2026 | 35928 | 0.450 |
Why?
| | Body Mass Index | 8 | 2024 | 2438 | 0.410 |
Why?
| | Male | 84 | 2026 | 72406 | 0.390 |
Why?
| | Aged | 52 | 2025 | 25947 | 0.380 |
Why?
| | Female | 84 | 2026 | 78376 | 0.370 |
Why?
| | Cause of Death | 8 | 2018 | 472 | 0.370 |
Why?
| | United States | 29 | 2025 | 15988 | 0.360 |
Why?
| | Risk Factors | 30 | 2026 | 10792 | 0.360 |
Why?
| | Resource Allocation | 2 | 2025 | 53 | 0.350 |
Why?
| | Graft Rejection | 6 | 2025 | 540 | 0.350 |
Why?
| | Living Donors | 6 | 2023 | 280 | 0.340 |
Why?
| | Acute Kidney Injury | 6 | 2023 | 866 | 0.320 |
Why?
| | Severity of Illness Index | 10 | 2025 | 2925 | 0.320 |
Why?
| | Humans | 96 | 2026 | 144957 | 0.310 |
Why?
| | Adult | 42 | 2026 | 40506 | 0.310 |
Why?
| | Health Expenditures | 2 | 2022 | 194 | 0.300 |
Why?
| | Retrospective Studies | 33 | 2026 | 17101 | 0.300 |
Why?
| | Kaplan-Meier Estimate | 11 | 2025 | 966 | 0.300 |
Why?
| | Follow-Up Studies | 16 | 2026 | 5417 | 0.280 |
Why?
| | Treatment Outcome | 21 | 2025 | 11695 | 0.260 |
Why?
| | Ohio | 10 | 2017 | 145 | 0.260 |
Why?
| | Aged, 80 and over | 23 | 2019 | 8279 | 0.260 |
Why?
| | Cytomegalovirus Infections | 3 | 2024 | 206 | 0.260 |
Why?
| | Renal Dialysis | 7 | 2018 | 462 | 0.250 |
Why?
| | Kidney Diseases | 4 | 2011 | 427 | 0.250 |
Why?
| | Electronic Health Records | 7 | 2017 | 1177 | 0.240 |
Why?
| | Coronary Angiography | 2 | 2026 | 323 | 0.240 |
Why?
| | Pancreas Transplantation | 1 | 2025 | 69 | 0.230 |
Why?
| | Postoperative Complications | 5 | 2026 | 2920 | 0.230 |
Why?
| | Computed Tomography Angiography | 1 | 2026 | 145 | 0.220 |
Why?
| | ABO Blood-Group System | 1 | 2025 | 57 | 0.210 |
Why?
| | Healthcare Disparities | 4 | 2025 | 728 | 0.210 |
Why?
| | Patient Navigation | 2 | 2017 | 104 | 0.210 |
Why?
| | Kidney | 7 | 2021 | 1496 | 0.210 |
Why?
| | Time Factors | 15 | 2025 | 7183 | 0.200 |
Why?
| | Prognosis | 10 | 2026 | 4293 | 0.200 |
Why?
| | Body Height | 1 | 2005 | 202 | 0.200 |
Why?
| | Knee Injuries | 1 | 2005 | 122 | 0.200 |
Why?
| | Health Services Accessibility | 4 | 2024 | 1099 | 0.200 |
Why?
| | Disease Progression | 10 | 2025 | 2852 | 0.200 |
Why?
| | Obesity | 6 | 2024 | 3082 | 0.200 |
Why?
| | Nephrology | 2 | 2021 | 60 | 0.190 |
Why?
| | Nephrologists | 1 | 2023 | 14 | 0.190 |
Why?
| | Travel | 2 | 2020 | 136 | 0.190 |
Why?
| | Donor Selection | 2 | 2021 | 79 | 0.190 |
Why?
| | Propensity Score | 6 | 2025 | 367 | 0.180 |
Why?
| | Informed Consent | 1 | 2024 | 198 | 0.180 |
Why?
| | Nutrition Surveys | 4 | 2021 | 282 | 0.180 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2005 | 216 | 0.180 |
Why?
| | Risk Assessment | 11 | 2021 | 3676 | 0.180 |
Why?
| | Stomach Diseases | 1 | 2021 | 20 | 0.170 |
Why?
| | Histamine H2 Antagonists | 1 | 2021 | 23 | 0.170 |
Why?
| | Cohort Studies | 12 | 2025 | 5965 | 0.170 |
Why?
| | Medicare | 2 | 2024 | 887 | 0.170 |
Why?
| | Transplants | 1 | 2021 | 39 | 0.170 |
Why?
| | Insulin Resistance | 3 | 2020 | 1241 | 0.160 |
Why?
| | Proteinuria | 1 | 2021 | 102 | 0.160 |
Why?
| | Survival Rate | 6 | 2026 | 2092 | 0.160 |
Why?
| | Comorbidity | 8 | 2021 | 1660 | 0.160 |
Why?
| | Body Weight | 1 | 2005 | 978 | 0.160 |
Why?
| | Proton Pump Inhibitors | 1 | 2021 | 109 | 0.160 |
Why?
| | Abdominal Fat | 1 | 2020 | 50 | 0.160 |
Why?
| | Age Factors | 9 | 2021 | 3335 | 0.160 |
Why?
| | Ventricular Function, Left | 3 | 2019 | 541 | 0.150 |
Why?
| | Sex Factors | 6 | 2024 | 2114 | 0.150 |
Why?
| | Incidence | 7 | 2025 | 2883 | 0.150 |
Why?
| | Nephrectomy | 1 | 2021 | 158 | 0.150 |
Why?
| | Chi-Square Distribution | 7 | 2016 | 529 | 0.150 |
Why?
| | Hypertension | 5 | 2017 | 1264 | 0.150 |
Why?
| | Magnesium | 1 | 2020 | 155 | 0.150 |
Why?
| | Coronary Artery Disease | 1 | 2026 | 741 | 0.150 |
Why?
| | Heart Transplantation | 2 | 2021 | 736 | 0.150 |
Why?
| | Career Choice | 1 | 2021 | 237 | 0.140 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 383 | 0.140 |
Why?
| | Internal Medicine | 1 | 2021 | 280 | 0.140 |
Why?
| | Mortality | 2 | 2018 | 376 | 0.140 |
Why?
| | Stroke Volume | 2 | 2019 | 651 | 0.140 |
Why?
| | Immunologic Factors | 1 | 2020 | 255 | 0.140 |
Why?
| | Program Evaluation | 2 | 2021 | 949 | 0.130 |
Why?
| | Gout Suppressants | 1 | 2017 | 20 | 0.130 |
Why?
| | Medicaid | 1 | 2022 | 462 | 0.130 |
Why?
| | Hyperuricemia | 1 | 2017 | 47 | 0.130 |
Why?
| | Hypernatremia | 1 | 2017 | 8 | 0.130 |
Why?
| | Terminology as Topic | 1 | 2019 | 255 | 0.130 |
Why?
| | Health Records, Personal | 1 | 2017 | 26 | 0.130 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 200 | 0.130 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 134 | 0.130 |
Why?
| | Hyponatremia | 1 | 2017 | 43 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 427 | 0.120 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.120 |
Why?
| | Uric Acid | 1 | 2017 | 166 | 0.120 |
Why?
| | Logistic Models | 7 | 2015 | 2119 | 0.120 |
Why?
| | Creatinine | 3 | 2023 | 506 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 253 | 0.120 |
Why?
| | Cytomegalovirus | 3 | 2024 | 168 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2020 | 365 | 0.110 |
Why?
| | Vascular Resistance | 2 | 2015 | 367 | 0.110 |
Why?
| | Hypokalemia | 1 | 2015 | 24 | 0.110 |
Why?
| | Contrast Media | 1 | 2018 | 488 | 0.110 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 318 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 3 | 2007 | 609 | 0.110 |
Why?
| | Diet, Reducing | 1 | 2015 | 91 | 0.110 |
Why?
| | Hyperkalemia | 1 | 2015 | 35 | 0.110 |
Why?
| | Multivariate Analysis | 7 | 2016 | 1540 | 0.110 |
Why?
| | Catheters | 1 | 2015 | 75 | 0.110 |
Why?
| | Program Development | 2 | 2015 | 370 | 0.110 |
Why?
| | Blood Pressure | 3 | 2017 | 1769 | 0.110 |
Why?
| | Adipokines | 1 | 2014 | 57 | 0.110 |
Why?
| | Electric Countershock | 1 | 2015 | 127 | 0.110 |
Why?
| | Patient Selection | 1 | 2018 | 719 | 0.100 |
Why?
| | Chelating Agents | 1 | 2014 | 73 | 0.100 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 299 | 0.100 |
Why?
| | Odds Ratio | 4 | 2014 | 1077 | 0.100 |
Why?
| | Patient Education as Topic | 2 | 2017 | 780 | 0.100 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 230 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 180 | 0.100 |
Why?
| | Primary Prevention | 1 | 2015 | 220 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 886 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 923 | 0.100 |
Why?
| | Lung Diseases | 1 | 2019 | 787 | 0.090 |
Why?
| | Bronchiolitis Obliterans | 2 | 2010 | 66 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 145 | 0.090 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2012 | 40 | 0.090 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 361 | 0.090 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 550 | 0.090 |
Why?
| | ROC Curve | 4 | 2025 | 615 | 0.090 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 392 | 0.090 |
Why?
| | Follicular Fluid | 1 | 2011 | 5 | 0.090 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2011 | 10 | 0.090 |
Why?
| | Bicarbonates | 1 | 2011 | 45 | 0.090 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 382 | 0.090 |
Why?
| | Sunscreening Agents | 1 | 2011 | 25 | 0.090 |
Why?
| | Coronary Disease | 2 | 2016 | 386 | 0.080 |
Why?
| | Carotid Stenosis | 1 | 2012 | 102 | 0.080 |
Why?
| | Bariatric Surgery | 1 | 2014 | 242 | 0.080 |
Why?
| | Infertility | 1 | 2011 | 55 | 0.080 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 413 | 0.080 |
Why?
| | Exercise Therapy | 1 | 2015 | 473 | 0.080 |
Why?
| | Stents | 2 | 2012 | 556 | 0.080 |
Why?
| | Internship and Residency | 1 | 2021 | 1257 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2010 | 2584 | 0.080 |
Why?
| | Motivation | 1 | 2015 | 610 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2010 | 13 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 419 | 0.080 |
Why?
| | Triglycerides | 1 | 2012 | 521 | 0.080 |
Why?
| | Adipose Tissue | 1 | 2014 | 653 | 0.080 |
Why?
| | Asthma | 1 | 2021 | 1768 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1389 | 0.080 |
Why?
| | Chronic Disease | 6 | 2011 | 1813 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 722 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2011 | 186 | 0.070 |
Why?
| | Health Surveys | 1 | 2011 | 518 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 354 | 0.070 |
Why?
| | Quality of Health Care | 1 | 2014 | 693 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2880 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2025 | 3890 | 0.070 |
Why?
| | Orthotic Devices | 1 | 2008 | 26 | 0.070 |
Why?
| | Elasticity | 1 | 2009 | 184 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 621 | 0.070 |
Why?
| | Young Adult | 7 | 2021 | 14126 | 0.070 |
Why?
| | Splenorenal Shunt, Surgical | 1 | 2007 | 3 | 0.070 |
Why?
| | Gait Disorders, Neurologic | 1 | 2008 | 45 | 0.070 |
Why?
| | Vitamin D | 1 | 2011 | 400 | 0.070 |
Why?
| | Brachial Artery | 1 | 2009 | 206 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 288 | 0.070 |
Why?
| | Insurance, Health | 2 | 2022 | 303 | 0.070 |
Why?
| | Esophageal and Gastric Varices | 1 | 2007 | 36 | 0.070 |
Why?
| | Mycoses | 1 | 2008 | 88 | 0.060 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2007 | 38 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1358 | 0.060 |
Why?
| | Diabetic Angiopathies | 1 | 2009 | 263 | 0.060 |
Why?
| | Hip Joint | 1 | 2008 | 172 | 0.060 |
Why?
| | Medical Staff | 1 | 2006 | 17 | 0.060 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2007 | 136 | 0.060 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2006 | 36 | 0.060 |
Why?
| | Veterans | 1 | 2018 | 1603 | 0.060 |
Why?
| | Diskectomy | 1 | 2005 | 24 | 0.060 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1186 | 0.060 |
Why?
| | Staff Development | 1 | 2006 | 61 | 0.060 |
Why?
| | Splanchnic Circulation | 1 | 2005 | 13 | 0.060 |
Why?
| | Survival Analysis | 4 | 2010 | 1385 | 0.060 |
Why?
| | Intervertebral Disc | 1 | 2005 | 36 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 98 | 0.060 |
Why?
| | Heart Failure | 4 | 2016 | 2323 | 0.060 |
Why?
| | Mesenteric Artery, Superior | 1 | 2005 | 28 | 0.060 |
Why?
| | Complementary Therapies | 1 | 2006 | 94 | 0.060 |
Why?
| | Intervertebral Disc Displacement | 1 | 2005 | 41 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 132 | 0.060 |
Why?
| | Adolescent | 9 | 2021 | 22453 | 0.060 |
Why?
| | Ileostomy | 1 | 2005 | 25 | 0.060 |
Why?
| | Proctocolectomy, Restorative | 1 | 2005 | 23 | 0.060 |
Why?
| | Astrocytoma | 1 | 2006 | 129 | 0.050 |
Why?
| | Prospective Studies | 5 | 2022 | 7997 | 0.050 |
Why?
| | Cross-Sectional Studies | 4 | 2024 | 5872 | 0.050 |
Why?
| | Poisson Distribution | 1 | 2005 | 78 | 0.050 |
Why?
| | Health Status | 2 | 2021 | 836 | 0.050 |
Why?
| | Hyperthermia, Induced | 1 | 2005 | 121 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2011 | 1339 | 0.050 |
Why?
| | Anterior Cruciate Ligament | 1 | 2005 | 101 | 0.050 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2005 | 120 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2024 | 172 | 0.050 |
Why?
| | Low Back Pain | 1 | 2005 | 107 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1416 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2020 | 1311 | 0.050 |
Why?
| | Cardiology | 1 | 2006 | 353 | 0.050 |
Why?
| | Waist Circumference | 2 | 2014 | 139 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1822 | 0.050 |
Why?
| | Breast Diseases | 1 | 2002 | 22 | 0.050 |
Why?
| | Nipples | 1 | 2002 | 10 | 0.050 |
Why?
| | Urinalysis | 1 | 2023 | 80 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4109 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2008 | 484 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1980 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2025 | 405 | 0.040 |
Why?
| | Laboratories | 1 | 2023 | 109 | 0.040 |
Why?
| | Pneumonia | 1 | 2008 | 631 | 0.040 |
Why?
| | Ambulatory Care Facilities | 2 | 2017 | 266 | 0.040 |
Why?
| | Catheter Ablation | 1 | 2005 | 353 | 0.040 |
Why?
| | Relative Value Scales | 1 | 2021 | 6 | 0.040 |
Why?
| | Microscopy | 1 | 2023 | 156 | 0.040 |
Why?
| | Contraceptive Agents | 1 | 2022 | 65 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 222 | 0.040 |
Why?
| | Work-Life Balance | 1 | 2021 | 22 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 170 | 0.040 |
Why?
| | Ultrasonography, Doppler | 2 | 2015 | 126 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2022 | 239 | 0.040 |
Why?
| | Biomarkers | 3 | 2020 | 4275 | 0.040 |
Why?
| | Diabetes Mellitus | 3 | 2016 | 1098 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3608 | 0.040 |
Why?
| | United States Public Health Service | 1 | 2019 | 9 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1327 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 2118 | 0.040 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 511 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1462 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2021 | 111 | 0.040 |
Why?
| | Health Services Needs and Demand | 2 | 2015 | 280 | 0.040 |
Why?
| | Sulfonylurea Compounds | 2 | 2010 | 51 | 0.040 |
Why?
| | Injections, Intra-Arterial | 1 | 2018 | 26 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 219 | 0.040 |
Why?
| | Adiposity | 2 | 2014 | 543 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 200 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 854 | 0.030 |
Why?
| | Child | 6 | 2021 | 22657 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 144 | 0.030 |
Why?
| | Acute Disease | 2 | 2010 | 1031 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1322 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2015 | 47 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 652 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 365 | 0.030 |
Why?
| | Protective Factors | 1 | 2016 | 99 | 0.030 |
Why?
| | Cystatin C | 1 | 2015 | 65 | 0.030 |
Why?
| | Smoking | 2 | 2016 | 1472 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 710 | 0.030 |
Why?
| | Survivors | 2 | 2009 | 520 | 0.030 |
Why?
| | Child, Preschool | 3 | 2021 | 11799 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2836 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1990 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 152 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2015 | 59 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 114 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2006 | 427 | 0.030 |
Why?
| | Equipment Failure | 1 | 2015 | 115 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 335 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 276 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 361 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2014 | 61 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 547 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 245 | 0.030 |
Why?
| | Blood Glucose | 2 | 2015 | 2330 | 0.030 |
Why?
| | Phosphorus | 1 | 2014 | 99 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 67 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1275 | 0.030 |
Why?
| | Adiponectin | 1 | 2015 | 244 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 93 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 768 | 0.030 |
Why?
| | Hypogonadism | 1 | 2014 | 90 | 0.020 |
Why?
| | Exercise Tolerance | 1 | 2015 | 283 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2015 | 417 | 0.020 |
Why?
| | Glucose Metabolism Disorders | 1 | 2013 | 11 | 0.020 |
Why?
| | Life Style | 1 | 2015 | 479 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2014 | 136 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2015 | 357 | 0.020 |
Why?
| | Hyperparathyroidism | 1 | 2012 | 11 | 0.020 |
Why?
| | Hypoalbuminemia | 1 | 2012 | 28 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 6053 | 0.020 |
Why?
| | Anthropometry | 1 | 2012 | 200 | 0.020 |
Why?
| | Body Composition | 1 | 2015 | 706 | 0.020 |
Why?
| | Hemoglobins | 1 | 2014 | 384 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1169 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 182 | 0.020 |
Why?
| | Glipizide | 1 | 2010 | 6 | 0.020 |
Why?
| | Glyburide | 1 | 2010 | 31 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1003 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2434 | 0.020 |
Why?
| | Length of Stay | 2 | 2006 | 1337 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2002 | 2456 | 0.020 |
Why?
| | Heart-Lung Transplantation | 1 | 2009 | 13 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2313 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 467 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 556 | 0.020 |
Why?
| | North America | 1 | 2009 | 310 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1184 | 0.020 |
Why?
| | Europe | 1 | 2009 | 412 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2738 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 265 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2009 | 139 | 0.020 |
Why?
| | Tacrolimus | 1 | 2009 | 196 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2008 | 157 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 710 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 549 | 0.020 |
Why?
| | Quality-Adjusted Life Years | 1 | 2007 | 121 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 798 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 18 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 269 | 0.020 |
Why?
| | Negativism | 1 | 2006 | 4 | 0.020 |
Why?
| | Primary Health Care | 1 | 2017 | 1734 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2007 | 162 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 530 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2947 | 0.020 |
Why?
| | Religion and Psychology | 1 | 2006 | 27 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2006 | 29 | 0.010 |
Why?
| | Secondary Prevention | 1 | 2007 | 255 | 0.010 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 424 | 0.010 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 104 | 0.010 |
Why?
| | Cerebrovascular Disorders | 1 | 2006 | 103 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2171 | 0.010 |
Why?
| | Morbidity | 1 | 2006 | 323 | 0.010 |
Why?
| | Muscle Strength | 1 | 2008 | 330 | 0.010 |
Why?
| | Gait | 1 | 2008 | 313 | 0.010 |
Why?
| | Metformin | 1 | 2009 | 319 | 0.010 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2005 | 41 | 0.010 |
Why?
| | Surgical Stapling | 1 | 2005 | 16 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 2008 | 441 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 636 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 221 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 847 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2005 | 157 | 0.010 |
Why?
| | Histological Techniques | 1 | 2004 | 38 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2006 | 919 | 0.010 |
Why?
| | Suture Techniques | 1 | 2005 | 131 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2008 | 705 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 236 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2010 | 947 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 555 | 0.010 |
Why?
| | Viremia | 1 | 2004 | 158 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 3192 | 0.010 |
Why?
| | Perioperative Care | 1 | 2005 | 231 | 0.010 |
Why?
| | Papilloma | 1 | 2002 | 49 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2884 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 732 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 174 | 0.010 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2005 | 279 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2006 | 1031 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 526 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2004 | 636 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1890 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1718 | 0.010 |
Why?
| | Pneumonia, Viral | 1 | 2004 | 384 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2006 | 1209 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4155 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 7191 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2832 | 0.010 |
Why?
| | Infant | 1 | 2010 | 10039 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2005 | 6434 | 0.010 |
Why?
| | Brain | 1 | 2006 | 2941 | 0.010 |
Why?
|
|
Arrigain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|